Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Heart failure ranked 'less important than potholes'
Tues June 28th - Heart failure is deemed less important than potholes in roads and pavements in the UK, according to an analysis published today. More
Cannabis users' increased risk of hospital admission
Tues June 28th - Canadian researchers have called for curbs on the globally rising levels of recreational cannabis because users have an increased risk of needing emergency care and hospital admission for any cause. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
guide to breast disorders guide to womb disorders guide to menopause Complete Women's Health: from The Royal College of Obstetricians and Gynaecologists For books and family gift ideas click here
RSS graphic XML Graphic

Vaccine 'urgently needed to tackle respiratory syncytial virus'

Friday May 20th 2022

A vaccine for respiratory syncytial virus is urgently needed because the infection is responsible for more than 100,000 deaths in young children a year, experts say today.

Authors of a new paper, published in today's edition of *The Lancet*, say RSV is estimated to cause one in 50 deaths among children under five, and one in 28 deaths in babies under six months.

RSV is responsible for about 3.6 million hospital admissions every year and in 2019, the acute lower respiratory infection was attributable to more than 100,000 deaths in children under five in 2019, with more than 45,000 of these being babies under six months old.

Almost all - 97% - of these RSV deaths were in low- and middle-income countries and the study authors say it highlights the urgent need to develop effective RSV vaccines and strategies that prioritise the most vulnerable groups.

Co-author Professor Harish Nair, chair of paediatric infectious diseases and global health at the University of Edinburgh, said: "RSV is the predominant cause of acute lower respiratory infection in young children and our updated estimates reveal that children six months and younger are particularly vulnerable, especially with cases surging as Covid-19 restrictions are easing around the world and the majority of the young children born in the last two years have never been exposed to RSV (and therefore have no immunity against this virus).

"With numerous RSV vaccine candidates in the pipeline, our estimates by narrower age ranges help to identify groups that should be prioritised, including pregnant people, so that children in the youngest age groups can be protected, similarly to current strategies which offer vaccines for whooping cough, typhoid, and tetanus to pregnant people."

A 2015 study found there were 33.1 million annual cases of RSV in children up to five years old, which resulted in 118,200 deaths.

The new figures for 2019 include modelling data from more than 100 new studies, which enabled the researchers to provide estimates for narrower age groups, including from 28 days to six months old.

They found there were 33 million RSV-associated acute lower respiratory infection episodes in children under five years old, which led to 3.6 million hospital admissions, 26,300 in-hospital deaths, and 101,400 RSV-attributable deaths overall.

For babies under six months old, there were 6.6 million RSV-associated acute lower respiratory infection episodes globally in 2019, leading to 1.4 million hospital admissions, 13,300 hospital deaths, and 45,700 overall deaths.

Xin Wang, co-author of the study from Nanjing Medical University, China and University of Edinburgh, added: "Our study estimates that three-quarters of RSVs deaths are happening outside of a hospital setting. This gap is even greater in LMICs, especially in children under six months old, where more than 80% of deaths are occurring in the community.

"This reflects the fact that access and availability to hospital care are still limited in these regions. Early identification of cases in the community and referral for hospital admission of sick children (particularly those with low oxygen saturation in peripheral blood), and universal effective and affordable immunisation programmes will be vital going forward."

Li Ym Wang X, Blau DM et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. *The Lancet* 20 May 2022


Tags: Flu & Viruses | Respiratory | World Health

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)